# Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix

> **NCT03256916** · PHASE3 · COMPLETED · sponsor: **Tata Memorial Hospital** · enrollment: 348 (actual)

## Conditions studied

- Carcinoma Cervix,Stage III

## Interventions

- **DRUG:** Nelfinavir
- **DRUG:** Cisplatin
- **RADIATION:** Pelvic EBRT and Brachytherapy

## Key facts

- **NCT ID:** NCT03256916
- **Lead sponsor:** Tata Memorial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-16
- **Primary completion:** 2024-05-28
- **Final completion:** 2024-05-28
- **Target enrollment:** 348 (ACTUAL)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03256916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03256916, "Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03256916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*